EP4341406 - COMPOUNDS FOR MODULATING UNC13A EXPRESSION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.02.2024 Database last updated on 15.07.2024 | |
Former | The international publication has been made Status updated on 26.11.2022 | Most recent event Tooltip | 12.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | [2024/13] | Inventor(s) | 01 /
VALAS, Ruben, E. Oceanside, CA 92056 / US | 02 /
LING, Kar, Yun Karen Carlsbad, CA 92010 / US | [2024/13] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2024/13] | Application number, filing date | 22805616.4 | 20.05.2022 | [2024/13] | WO2022US30335 | Priority number, date | US202163191905P | 21.05.2021 Original published format: US 202163191905 P | [2024/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022246251 | Date: | 24.11.2022 | Language: | EN | [2022/47] | Type: | A2 Application without search report | No.: | EP4341406 | Date: | 27.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.11.2022 takes the place of the publication of the European patent application. | [2024/13] | Search report(s) | International search report - published on: | US | 29.12.2022 | Classification | IPC: | C12N15/113, A61K31/712, A61K31/7125, A61P25/28 | [2024/13] | CPC: |
C12N15/113 (EP);
C12N2310/11 (EP);
C12N2310/315 (EP);
C12N2310/322 (EP);
C12N2310/3341 (EP)
| C-Set: |
C12N2310/322, C12N2310/3525 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/13] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBINDUNGEN ZUR MODULATION DER UNC13A-EXPRESSION | [2024/13] | English: | COMPOUNDS FOR MODULATING UNC13A EXPRESSION | [2024/13] | French: | COMPOSÉS POUR MODULER L'EXPRESSION D'UNC13A | [2024/13] | Entry into regional phase | 15.12.2023 | National basic fee paid | 15.12.2023 | Search fee paid | 15.12.2023 | Designation fee(s) paid | 15.12.2023 | Examination fee paid | Examination procedure | 15.12.2023 | Examination requested [2024/13] | 10.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.03.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YA]US2011195848 (ROOPRA AVTAR S [US], et al) [Y] 3, 5, 6, 8/(5,6), 10 * . Especially SEQ ID NO: 221 *[A] 7, 8/7; | [YA]WO2019051173 (IONIS PHARMACEUTICALS INC [US]) [Y] 1-3, 5, 6, 8/(5,6), 10 * . Especially claims 1, 11 * [A] 7, 8/7; | [Y] - Deng Lunbin, Kaeser Pascal S., Xu Wei, Südhof Thomas C., "RIM Proteins Activate Vesicle Priming by Reversing Auto-Inhibitory Homodimerization of Munc13", Neuron, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20110127), vol. 69, no. 2, doi:10.1016/j.neuron.2011.01.005, ISSN 0896-6273, pages 317 - 331, XP093020823 [Y] 1-3 * . Especially pg 325 col 2 para 2, pg 329 col 2 para 3. * DOI: http://dx.doi.org/10.1016/j.neuron.2011.01.005 |